JAN 10, 2017 01:30 PM PST

Existing Drug Halts Triple-Negative Breast Cancer Metastasis

WRITTEN BY: Xuan Pham

For aggressive, intractable triple-negative breast cancers, there’s still hope. Researchers at the Mayo Clinic found that a pre-existing drug that’s shown positive effects in another type of breast cancer may also halt the spread of triple-negative cancer.

Breast cancer is generally classified into 3 subtypes according to the presence or absence of three receptors: estrogen, progesterone, and the epidermal growth factor receptor 2 (HER2). Typically, breast cancers positive for estrogen or HER2 respond well to hormone therapy. However, cancers that are negative for these receptors have proven more difficult to treat and manage. In particular, cancers that are negative for all three receptors, known as triple negative breast cancer, are most notorious for evading treatment.

In studying how the receptor-positive breast cancers respond to treatment, researchers at the Mayo Clinic found that a class of inhibitors may also be effective against receptor-negative breast cancers.

The drugs are known as CDK 4/6 inhibitors, and they work by blocking the enzyme cyclin-dependent kinases (CDKs). Many cancers have high CDK activity, which promotes the unregulated proliferation of cancer cells. Inhibitors of this enzyme pathway have been shown to be effective against ER-positive and HER2-positive breast cancers. Recently, Palbociclib – another CDK 4/6 inhibitor – showed promising Phase II trial results in patients with HER2-negative breast cancer too.

CDK 4/6 inhibitors have previously been tested in triple-negative breast cancers with disappointing results – these drugs didn’t seem to reduce the growth of these cancers. But in applying the drugs to a triple-negative breast cancer mouse models, researchers at the Mayo Clinic found that metastasis was halted. In essence the drug stopped the cancer from invading to other parts of the body.

Of note, metastasis is one of the biggest conditions that severely undermines the effectiveness of anticancer treatments. As such, a drug that can halt metastasis is still quite important, even if it can’t reduce the growth of the primary tumor. Perhaps this will lead to combination therapy that targets both the primary tumor and prevent spread to secondary organs, thereby increasing the survival rate.

"These findings may provide a new treatment for the prevention of cancer metastasis. Mayo Clinic is now developing new studies that will focus on the role of CDK 4/6 inhibitors and their potential to inhibit cancer metastasis in women with triple-negative breast cancer who are at highest risk for cancer metastasis,” said Matthew Goetz, the study’s co-author.

Additional sources: MNT, Mayo Clinic

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 17, 2019
Cancer
OCT 17, 2019
Self-Destructing Cancer: Study Stops Chain Reaction of Tumor Growth
A new study reveals that stopping one protein from functioning can cause some cancer cells to die from stress....
OCT 17, 2019
Cancer
OCT 17, 2019
Understanding osteosarcoma in kids and dogs
New research published in the Nature journal, Communications Biology, shows evidence for a comparative study that scientists could use to improve treatment...
OCT 17, 2019
Cancer
OCT 17, 2019
Vitamin A consumption decreases risk of skin cancer
We know that vitamin A is important for our bodies’ growth and development, in particular for eye, reproductive, and skin health. Now new research sh...
OCT 17, 2019
Cancer
OCT 17, 2019
Urine test detects cancer: watch out for blue pee!
New research from MIT engineers and Imperial and published in Nature Nanotechnology could change the way to detect cancer. The study highlights the develop...
OCT 17, 2019
Cancer
OCT 17, 2019
The golden future of cancer treatment
A study published recently in Chemistry -- A European Journal features research on the golden cancer treatments of the future – literally. Current me...
OCT 17, 2019
Cancer
OCT 17, 2019
Can eating mushrooms reduce the risk of prostate cancer?
Now here’s a question: have you eaten your mushrooms yet today? Although mushrooms may not be one of the typically-touted snacks in the healthcare wo...
Loading Comments...